SG3 Management’s Johnson & Johnson JNJ Stock Holding History

SG3 Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,500	Closed	-$323K	–	353
2018 Q4	$323K	Buy	+2,500	New	+$349K	0.08%	131

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SG3 Management's JNJ Position: Q2 2022 in Review

SG3 Management sold out of Johnson & Johnson (JNJ) in Q2 2022, closing a stake of 6,000 shares — an estimated $1.06M sold.

SG3 Management first reported a position in JNJ in Q4 2019 and held it in 3 quarters. The position peaked at $2.52M in Q4 2019. 3,671 funds tracked by Wall St. Rank hold JNJ as of Q2 2022.

SG3 Management reported no remaining Johnson & Johnson position as of Q2 2022 after selling out during the quarter.
SG3 Management sold 6,000 Johnson & Johnson shares in Q2 2022, an estimated $1.06M.
SG3 Management first reported a position in Johnson & Johnson in Q4 2019 and held it in 3 quarters.
SG3 Management's Johnson & Johnson position peaked at $2.52M in Q4 2019.
3,671 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2022.

Based on SG3 Management's 13F filing for Q2 2022, filed 15 Aug 2022.